Rankings
▼
Calendar
IMA Q3 2021 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$69M
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
+32.4% YoY
Gross Profit
-$10M
-257.0% margin
Operating Income
-$15M
-387.7% margin
Net Income
-$15M
-387.5% margin
EPS (Diluted)
$-0.40
QoQ Revenue Growth
+5.6%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$262M
Total Liabilities
$58M
Stockholders' Equity
$203M
Cash & Equivalents
$246M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$3M
+32.4%
Gross Profit
-$10M
-$4M
-119.4%
Operating Income
-$15M
-$6M
-133.0%
Net Income
-$15M
-$6M
-133.3%
← FY 2021
All Quarters
Q4 2021 →